Lepu Biopharma Co., Ltd. (HKG:2157)
7.94
+0.49 (6.58%)
Sep 30, 2025, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 14.33 billion as of September 30, 2025. Its market cap has increased by 190.82% in one year.
Market Cap
14.33B
Enterprise Value
14.71B
Revenue
767.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.94
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has increased from 11.84B to 14.33B, an increase of 20.99%. That is a compound annual growth rate of 5.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 14.33B | 219.68% |
Dec 31, 2024 | 4.48B | -35.85% |
Dec 29, 2023 | 6.99B | -42.72% |
Dec 30, 2022 | 12.20B | 3.00% |
Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 279.26B |
Hansoh Pharmaceutical Group Company | 210.92B |
JD Health International | 206.50B |
Innovent Biologics | 159.71B |
WuXi Biologics | 158.73B |
Sino Biopharmaceutical | 142.12B |
Akeso | 122.24B |
Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |